ClinicalTrials.gg
Not yet recruitingNCT07926932SpeedClimEMSUpdated Nov 9, 2026

Whole-Body Electromyostimulation and Speed Climbing

An interventional study of Traditional warm-up and Isolated WB-EMS without voluntary exercises in Athletic Performance, sponsored by University of Erlangen-Nürnberg Medical School. Not yet recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by University of Erlangen-Nürnberg Medical School · Not applicable, Interventional, and Other

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Whole-body electromyostimulation is a versatile training technology characterised in particular by its ability to stimulate large muscle groups simultaneously, whilst maintaining an appropriate stimulation intensity for each. Joint-friendly application, time-efficiency, individualised use and, when used correctly , a low risk of injury and damage are among the distinctive features of WB-EMS. Whilst the research focus of WB-EMS lies primarily on preventive and rehabilitative issues , whilst its use in elite sport is not new, the investigation of potential performance enhancement following prior neuromuscular activation ('Post-Activation Performance Enhancement', PAPE) via EMS represents a new research approach. Traditionally, PAPE is predominantly induced by high-intensity strength training, plyometric or ballistic exercises . Electromyostimulation, through its comprehensive neuromuscular activation with comparatively low mechanical load, could be an alternative or complement to these traditional approaches. However, the scientific evidence on EMS-induced PAPE remains The aim of this study is to evaluate the effects of different neuromuscular activation protocols, with and without whole-body EMS, on performance in speed climbing.

The research question is therefore: Can competition performance in speed climbing be enhanced through pre-activation using whole-body EMS? By comparing four different methodological approaches, with and without whole-body EMS, for pre-activation prior to a competition-specific task, the most effective variant of 'Post-Activation Performance Enhancement' (PAPE) will be identified.

02

Conditions studied

  • Athletic Performance

Keywords

  • whole-body electromyostimulation
  • speed-climbing
  • Post-Activation Performance Enhancement
  • intervention
  • athletes
03

In context

Lead sponsor

University of Erlangen-Nürnberg Medical School is the lead sponsor of 276 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Competition record (15 m climbing wall) in 2026: \< 10 s (men), \< 12 s (women)
  • Competition experience at regional level

Exclusion criteria

Exclusion Criteria:

  • for WB-EMS (according to WB-EMS contraindication list)
  • Current illnesses, infections

Inclusion and exclusion criteria are checked by the study physician before the participant is enrolled.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
18 participants (estimated)

Study arms

  • Sham comparator
    Conventional warm up

    Standardised, conventional warm-up (7 mins) to prepare for competition

    Other: Isolated WB-EMS without voluntary exercises · Other: WB-EMS I · Other: WB-EMS II

  • Active comparator
    Isolated WB-EMS Application

    Static WB-EMS application at different joint angles/postures. 7 minutes at high stimulation intensity

    Other: Traditional warm-up · Other: WB-EMS I · Other: WB-EMS II

  • Active comparator
    Superimposed WB-EMS I

    WB-EMS combined with individual warm-up (WA+WB-EMS), focusing on high voluntary exertion, 7 minutes at low stimulation intensity

    Other: Traditional warm-up · Other: Isolated WB-EMS without voluntary exercises · Other: WB-EMS II

  • Active comparator
    Superimposed WB-EMS II

    WB-EMS is combined with an individual warm-up (WA+WB-EMS), focusing on high stimulation intensity (7 mins) whilst performing a low level of voluntary exertion.

    Other: Traditional warm-up · Other: Isolated WB-EMS without voluntary exercises · Other: WB-EMS I

Interventions

  • OtherTraditional warm-up

    Standardised, conventional warm-up (7 mins) to prepare for competition

  • OtherIsolated WB-EMS without voluntary exercises

    7 min of static WB-EMS application at different joint angles/postures at high stimulation intensity

  • OtherWB-EMS I

    7 min WB-EMS combined with individual warm-up (WA+WB-EMS), focusing on high voluntary exertion and low stimulation intensity.

  • OtherWB-EMS II

    7 min WB-EMS combined with individual warm-up (WA+WB-EMS), focusing on low to moderate voluntary exertion and high stimulation intensity.

06

What researchers measure

Primary outcomes

  1. Speed-climbing performance (seconds)

    Time taken to climb a standardised, 15-metre-high climbing wall as quickly as possible (in seconds, as recorded by the competition timing system) assessed following each of the four PAPE protocols.

    Time frame: Immediately after each of the four experimental PAPE interventions, once per experimental session.

Secondary outcomes

  1. Perceived Physical State Scale (PEPS)

    Perceived Physical State Scale as assessed via the WKV-questionnaire provided by Kleinert, 2016. The WKV comprises four dimensions: physical activation, perceived fitness, flexibility, and health. Each dimension consists of five items rated on a 6-point scale (0-5): Higher scores indicating a more favorable perceived physical condition.

    Time frame: Immediately after each of the four experimental PAPE interventions, once per experimental session.

  2. Flow experience and associated psychological responses

    Flow experience as assessed using the Flow Short Scale (FSS; Rheinberg et al., 2003), comprising 10 items assessing flow experience , three items assessing performance-related worry, and three additional items assessing perceived challenge-skill balance. The overall score is calculated as the mean of the 10 items, ranging from 1 to 7, with higher scores indicating greater flow experience.

    Time frame: Immediately after each of the four experimental PAPE interventions, once per experimental session.

07

Study locations

1 site
  • Institute of Radiology, University Hospital Erlangen
    Erlangen, 91052, Germany
08

References and documents

Publications

  • Adams F, Kohl M, Stengel SV, Filipovic A, Uder M, Kemmler W. Effects of Longitudinal Whole-Body Electromyostimulation on Maximum Strength and Power in Sportspeople and Athletes-A Systematic Review and Meta-Analysis. Muscles. 2026 Jul 8;5(3):49. doi: 10.3390/muscles5030049. PubMed 42496380 ↗

Individual participant data

Plan to share: No — Individual participant data (IPD) sharing is currently not planned. Any future sharing of anonymized individual-level data would be subject to applicable ethical and data protection requirements.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Jun 2027, 7 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 27, 2026
First posted
Nov 9, 2026
StartEst.
Nov 15, 2026
Primary completionEst.
Jun 30, 2027
CompletionEst.
Dec 31, 2027
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07926932
Collaborators
Deutscher Alpenverein (DAV)
Responsible party
Wolfgang Kemmler, PhD (Research Director, University of Erlangen-Nürnberg Medical School) — Principal investigator
First posted
Nov 9, 2026
Start date
Nov 15, 2026 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Nov 9, 2026

Study contacts

Wolfgang Kemmler, PhD
Contact
wolfgang.kemmler@fau.de
++49 90131 8523999
Pia Zuber, MSc
Contact
pia.zuber@fau.de
++49 9131 8523999
Wolfgang Kemmler, PhD
principal investigator · Institute of Radiology, University Hospital Erlangen, Germany

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion